Anacor to Detail Chemistry Behind Lead Compounds
Date Posted: Monday, September 18, 2006
Anacor Pharmaceuticals has announced it has made two presentations at the American Chemical Society National Meeting & Exposition this week in San Francisco.
Researchers have made an oral presentation on the chemistry and discovery of AN2690, Anacor's topical antifungal drug candidate being developed for onychomycosis, a fungal infection of the toenail and nail bed, as well as a poster presentation on the discovery of AN0128, Anacor's treatment for atopic dermatitis.
The conference is being held at the Moscone Center.
AN0128 Poster Presentation:
Discovery and SAR of diphenylborinic acid picolinate esters as a potent antibacterial and anti-inflammatory agent for the treatment of skin diseases
General Poster Session : 7 to 9 p.m., Wednesday, Sept. 13, Moscone Center - Hall D
AN2690 Oral Presentation:
Discovery and SAR of a boron-containing clinical molecule (AN-2690) for topical onychomycosis treatment
General Oral Session : 1:30 to 4:50 p.m., Tuesday, Sept. 12, Moscone Center - Room 103
Further Information: http://www.anacor.com/